Please provide your email address to receive an email when new articles are posted on . Adbry is approved for moderate to severe atopic dermatitis. The autoinjector delivers a single 300 mg/mL dose.
If you have atopic dermatitis, a skin condition commonly known as eczema, prescription creams or other topical medicines and moisturizers are usually enough to manage it. However, if your eczema is ...
The Adbry autoinjector is for use in adults only. A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results